246 related articles for article (PubMed ID: 33269952)
1. Interictal amylin levels in chronic migraine patients: A case-control study.
Irimia P; Martínez-Valbuena I; Mínguez-Olaondo A; Domínguez-Vivero C; Sánchez-Arias JA; Martínez-Vila E; Luquin MR; Leira R
Cephalalgia; 2021 Apr; 41(5):604-612. PubMed ID: 33269952
[TBL] [Abstract][Full Text] [Related]
2. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
Kamm K; Straube A; Ruscheweyh R
Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
[TBL] [Abstract][Full Text] [Related]
5. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
6. Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Alvarez R; Larrosa D; Ramón C; Pascual J
Cephalalgia; 2015 Apr; 35(4):310-6. PubMed ID: 24847167
[TBL] [Abstract][Full Text] [Related]
7. No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.
Cernuda-Morollón E; Riesco N; Martínez-Camblor P; Serrano-Pertierra E; García-Cabo C; Pascual J
Headache; 2016 Oct; 56(9):1448-1454. PubMed ID: 27634731
[TBL] [Abstract][Full Text] [Related]
8. OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine.
Cernuda-Morollón E; Ramón C; Martínez-Camblor P; Serrano-Pertierra E; Larrosa D; Pascual J
Pain; 2015 May; 156(5):820-824. PubMed ID: 25735000
[TBL] [Abstract][Full Text] [Related]
9. [Frequent episodic migraine and calcitonin gene-related peptide. Influence of treatment with topiramate and zonisamide on levels of the peptide].
Garcia-Estevez DA; Pardo-Parrado M; Silvarrey-Rodriguez S
Rev Neurol; 2017 Aug; 65(4):153-156. PubMed ID: 28726232
[TBL] [Abstract][Full Text] [Related]
10. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
[TBL] [Abstract][Full Text] [Related]
11. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine.
Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC
Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383
[TBL] [Abstract][Full Text] [Related]
12. Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients.
Fekrazad R; Sardarian A; Azma K; Karami M; Borhani-Haghighi A; Gharesi-Fard B; Movahedi B
Neurol Sci; 2018 Jul; 39(7):1217-1223. PubMed ID: 29654418
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods.
Fusayasu E; Kowa H; Takeshima T; Nakaso K; Nakashima K
Pain; 2007 Apr; 128(3):209-214. PubMed ID: 17123735
[TBL] [Abstract][Full Text] [Related]
14. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial.
Ghorbani Z; Rafiee P; Fotouhi A; Haghighi S; Rasekh Magham R; Ahmadi ZS; Djalali M; Zareei M; Razeghi Jahromi S; Shahemi S; Mahmoudi M; Togha M
J Headache Pain; 2020 Feb; 21(1):22. PubMed ID: 32093657
[TBL] [Abstract][Full Text] [Related]
15. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks.
Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J
Pain; 2000 May; 86(1-2):133-8. PubMed ID: 10779670
[TBL] [Abstract][Full Text] [Related]
16. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.
Ramón C; Cernuda-Morollón E; Pascual J
Curr Opin Neurol; 2017 Jun; 30(3):281-286. PubMed ID: 28234796
[TBL] [Abstract][Full Text] [Related]
18. CGRP and PACAP-38 play an important role in diagnosing pediatric migraine.
Liu J; Wang G; Dan Y; Liu X
J Headache Pain; 2022 Jun; 23(1):68. PubMed ID: 35698032
[TBL] [Abstract][Full Text] [Related]
19. Endothelial progenitor cells: a new key for endothelial dysfunction in migraine.
Rodríguez-Osorio X; Sobrino T; Brea D; Martínez F; Castillo J; Leira R
Neurology; 2012 Jul; 79(5):474-9. PubMed ID: 22815557
[TBL] [Abstract][Full Text] [Related]
20. Can calcitonin gene-related peptide (CGRP) and pentraxin-3 (PTX-3) be useful in diagnosing acute migraine attack?
Vural S; Albayrak L
J Recept Signal Transduct Res; 2022 Dec; 42(6):562-566. PubMed ID: 35895308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]